Rigel Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析

◆英語タイトル:Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4176
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥24,150見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥48,300見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥72,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Rigel Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Rigel Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Rigel Pharmaceuticals, Inc. (Rigel or ‘the company’) is a clinical-stage drug development company that commercializes and sells novel, targeted drugs in immunology, inflammatory, autoimmune, oncology and immuno-oncology related therapeutic areas. It conducts various clinical trails and receives approval from the US Food and Drug Administration (FDA) before implementing on various patients. In addition, it collaborates with various pharmaceutical companies for developing therapeutic drugs. The company is headquartered in South San Francisco, California, the US.

Scope

- Detailed information on Rigel Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Rigel Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Rigel Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Rigel Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Rigel Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Rigel Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Rigel Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Rigel Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Rigel Pharmaceuticals, Inc.: Company Overview
Rigel Pharmaceuticals, Inc.: Overview and Key Facts
Rigel Pharmaceuticals, Inc.: Overview
Rigel Pharmaceuticals, Inc.: Key Facts
Rigel Pharmaceuticals, Inc.: Key Employees
Rigel Pharmaceuticals, Inc.: Key Employee Biographies
Rigel Pharmaceuticals, Inc.: Major Products and Services
Rigel Pharmaceuticals, Inc.: Company History
Rigel Pharmaceuticals, Inc.: Management Statement
Rigel Pharmaceuticals, Inc.: Locations and Subsidiaries
Rigel Pharmaceuticals, Inc.: Key Competitors
Rigel Pharmaceuticals, Inc.: Company Analysis
Rigel Pharmaceuticals, Inc.: Business Description
Rigel Pharmaceuticals, Inc.: SWOT Analysis
Rigel Pharmaceuticals, Inc.: SWOT Overview
Rigel Pharmaceuticals, Inc.: Strengths
Rigel Pharmaceuticals, Inc.: Weaknesses
Rigel Pharmaceuticals, Inc.: Opportunities
Rigel Pharmaceuticals, Inc.: Threats
Rigel Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Rigel Pharmaceuticals, Inc.: Financial Deals Overview
Rigel Pharmaceuticals, Inc.: Targets and Partners
Rigel Pharmaceuticals, Inc.: Top Deals 2016 – 2020YTD*
Rigel Pharmaceuticals, Inc.: Advisors
Rigel Pharmaceuticals, Inc.: Top Legal Advisors
Rigel Pharmaceuticals, Inc.: Top Financial Advisors
Rigel Pharmaceuticals, Inc.: Capital Raising
Rigel Pharmaceuticals, Inc.: Partnership
Rigel Pharmaceuticals, Inc.: Recent Developments
Rigel Pharmaceuticals, Inc.: News and Events Summary
Rigel Pharmaceuticals, Inc.: Corporate Governance
Rigel Pharmaceuticals, Inc.: Financial Performance
Rigel Pharmaceuticals, Inc.: Market Developments
Rigel Pharmaceuticals, Inc.: Research & Development
Rigel Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Rigel Pharmaceuticals, Inc.: Key Facts
Table 2: Rigel Pharmaceuticals, Inc.: Key Employees
Table 3: Rigel Pharmaceuticals, Inc.: Company History
Table 4: Rigel Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Rigel Pharmaceuticals, Inc.: Key Competitors
Table 6: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Rigel Pharmaceuticals, Inc.: Targets and Partners
Table 8: Rigel Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*
Table 9: Rigel Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Rigel Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Rigel Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 12: Rigel Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 13: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 14: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 15: Rigel Pharmaceuticals, Inc.: News and Events Summary
Table 16: Rigel Pharmaceuticals, Inc.: Corporate Governance
Table 17: Rigel Pharmaceuticals, Inc.: Financial Performance
Table 18: Rigel Pharmaceuticals, Inc.: Market Developments
Table 19: Rigel Pharmaceuticals, Inc.: Research & Development
Table 20: Rigel Pharmaceuticals, Inc.: Strategy and Operations

★海外企業調査レポート[Rigel Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Societe Generale Private Banking:企業の戦略・SWOT・財務情報
    Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report Summary Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Unchained Labs-製薬・医療分野:企業M&A・提携分析
    Summary Unchained Labs is a life science tools company which offers protein stability assessment products for biologics. Its product portfolio includes UNcle (biologics stability platform), HUNK (aggregation predictor), pUNk (protein sizing system), GRUNT (automated formulation preparation system), …
  • AcelRx Pharmaceuticals Inc (ACRX):医療機器:M&Aディール及び事業提携情報
    Summary AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo outside the US), is a single sufentanil sublingual tablet for the treatment of moderate-t …
  • Alnylam Pharmaceuticals Inc (ALNY):企業の財務・戦略的SWOT分析
    Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Ocular Therapeutix Inc (OCUL):製薬・医療:M&Aディール及び事業提携情報
    Summary Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company’s products include DEXTENZA, sustained release travoprost and posterior …
  • Statewide Superannuation Pty Ltd:企業の戦略的SWOT分析
    Statewide Superannuation Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Collegium Pharmaceutical Inc (COLL):企業の財務・戦略的SWOT分析
    Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Fortress Biotech Inc (FBIO):企業の財務・戦略的SWOT分析
    Fortress Biotech Inc (FBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Hopewell Holdings Ltd (54):企業の財務・戦略的SWOT分析
    Hopewell Holdings Ltd (54) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Avista Corporation (AVA):電力:M&Aディール及び事業提携情報
    Summary Avista Corporation (Avista) is an electric and natural gas utility. The company produces, transmits, and distributes electricity; and supplies natural gas on retail and wholesale basis. It sources electricity from its facilities and contracted hydroelectric, thermal and wind generation facil …
  • NGK Insulators Ltd (5333):企業の財務・戦略的SWOT分析
    NGK Insulators Ltd (5333) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Foley Family Wines Limited:企業の戦略・SWOT・財務情報
    Foley Family Wines Limited - Strategy, SWOT and Corporate Finance Report Summary Foley Family Wines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • United Spirits Ltd:企業の戦略・SWOT・財務情報
    United Spirits Ltd - Strategy, SWOT and Corporate Finance Report Summary United Spirits Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Exillon Energy Plc (EXI):企業の財務・戦略的SWOT分析
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • Celyad SA (CYAD):企業の財務・戦略的SWOT分析
    Summary Celyad SA (Celyad), formerly Cardio3 BioSciences, is a clinical-stage biopharmaceutical company that offers discovery and development of engineered cell therapies. The company offers C-Cure, a cell-based reparative therapy to treat heart failure. It offers C-Cathez, an intraventricular injec …
  • CollPlant Ltd:医療機器:M&Aディール及び事業提携情報
    Summary CollPlant Ltd (CollPlant) is a regenerative medicine company that develops and commercializes tissue repair products. The company’s product categories include orthobiologics, wound care, and pipeline products. Its orthobiologics products comprise VergenixSTR and VergenixBVF. CollPlant’s woun …
  • EA Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary EA Pharma Co Ltd (EA Pharma), formerly Ajinomoto Pharmaceuticals Co Ltd, a subsidiary of Eisai Co Ltd, is a clinical research organization that develops, manufactures and sells pharmaceutical products. The organization develops pharmaceutical products based on amino acid-related technologies …
  • Shionogi & Co., Ltd.:企業のM&A・事業提携・投資動向
    Shionogi & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shionogi & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Globe Specialty Metals, Inc.:企業の戦略・SWOT・財務分析
    Globe Specialty Metals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Globe Specialty Metals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆